Treatment of neuroleptic-resistant mania and schizoaffective disorders.
R
R
De Beaurepaire
D014150:Antipsychotic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D001714:Bipolar Disorder / Q000188:drug therapy* / Q000523:psychology; D004357:Drug Synergism; D004359:Drug Therapy, Combination; D006220:Haloperidol / Q000627:therapeutic use; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D009543:Nifedipine / Q000494:pharmacology / Q000627:therapeutic use*; D011618:Psychotic Disorders / Q000188:drug therapy* / Q000523:psychology; D014700:Verapamil / Q000627:therapeutic use
D014150:Antipsychotic Agents; D008094:Lithium; D014700:Verapamil; D009543:Nifedipine; D006220:Haloperidol